EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Rituximab in severe skin diseases: target, disease, and dose

Daniel D Bennett, Maro Ohanian, Christian T Cable

Clinical Pharmacology: Advances and Applications · 2010

DOI: 10.2147/cpaa.s10929 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Pharmacology: Advances and Applications, 2010. Verfasst von Daniel D Bennett und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Division of Hematology and Oncology, Scott and White Healthcare, Texas A&M Health Science Center College of Medicine. Temp…. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

atopic dermatitislivedoid vasculopathypemphigus vulgarispharmacokineticsrheumatoid arthritisrituximab

Autor:innen und Institutionen

  • Department of Dermatology, Division of Hematology and Oncology, Scott and White Healthcare, Texas A&M Health Science Center College of Medicine. Temple, TX, USA.

Zitieren

APA

Bennett, D. D., Ohanian, M., & Cable, C. T. (2010). Rituximab in severe skin diseases: target, disease, and dose. Clinical Pharmacology: Advances and Applications. https://doi.org/10.2147/cpaa.s10929

Vancouver

Bennett DD, Ohanian M, Cable CT. Rituximab in severe skin diseases: target, disease, and dose. Clinical Pharmacology: Advances and Applications. 2010. doi:10.2147/cpaa.s10929

BibTeX
@article{Bennett2010,
  author = {Bennett, Daniel D and Ohanian, Maro and Cable, Christian T},
  title = {Rituximab in severe skin diseases: target, disease, and dose},
  journal = {Clinical Pharmacology: Advances and Applications},
  year = {2010},
  doi = {10.2147/cpaa.s10929}
}
Kostenlos starten →